Business
FDA Approves First Treatment for Niemann-Pick Disease, Type C - FDA.gov
The FDA approved Miplyffa (arimoclomol), an oral medication for the treatment of Neimann-Pick disease, type C (NPC).
By: FDA.gov
- Sep 21 2024
- 0
- 0 Views
For Immediate Release:
September 20, 2024
Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Neimann-Pick disease, type C (NPC). M… [+3778 chars]